Lee's Pharmaceutical Holdings Limited (HKG:0950)
Hong Kong · Delayed Price · Currency is HKD 1.160
+0.100 (9.43%)
Jun 1, 2026, 3:51 PM HKT
HKG:0950 Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 91.94 | 93.1 | 16.7 | 51.28 | 1,987 |
Depreciation & Amortization | 97.59 | 99.3 | 107.95 | 125.52 | 126.97 |
Other Amortization | 58.06 | 48.43 | 41.55 | 26.98 | 19.9 |
Loss (Gain) From Sale of Assets | 0.2 | -0.14 | -41.63 | -0.24 | -0.04 |
Asset Writedown & Restructuring Costs | 16.52 | 25.91 | 33.31 | 2.68 | 235.09 |
Loss (Gain) From Sale of Investments | -0.35 | 0.38 | 1.43 | 46.36 | -2,300 |
Loss (Gain) on Equity Investments | 1.85 | 0.84 | 0.87 | 1.1 | 3.5 |
Stock-Based Compensation | 0.52 | 0.41 | 0.79 | 12.11 | 16.89 |
Provision & Write-off of Bad Debts | 0.16 | 13.7 | 1.28 | -0.26 | 90.28 |
Other Operating Activities | 10.06 | 11.07 | 26.16 | 33.1 | -33.8 |
Change in Accounts Receivable | -19.22 | -82.46 | 21.09 | 39.9 | -1.95 |
Change in Inventory | -83.39 | -7.22 | -61.96 | 43.28 | 43.34 |
Change in Accounts Payable | 28.13 | 69.98 | -26.82 | 39.48 | -11.35 |
Change in Other Net Operating Assets | 130.85 | -31.28 | -10.63 | -137.67 | 34.47 |
Operating Cash Flow | 332.9 | 242.01 | 110.08 | 283.63 | 210.68 |
Operating Cash Flow Growth | 37.56% | 119.85% | -61.19% | 34.63% | -3.76% |
Capital Expenditures | -66.63 | -43.96 | -29.43 | -17.46 | -50.7 |
Sale of Property, Plant & Equipment | 0.09 | 0.24 | 0.11 | 0.88 | 0.04 |
Cash Acquisitions | - | - | -0.02 | - | - |
Sale (Purchase) of Intangibles | -164.93 | -141.54 | -110.72 | -196.37 | -320.03 |
Investment in Securities | -7 | -8.64 | -6.7 | -45.5 | -2.17 |
Other Investing Activities | 2.7 | 3.66 | 1.53 | 2.39 | 2.58 |
Investing Cash Flow | -235.77 | -190.23 | -145.22 | -256.05 | -370.28 |
Long-Term Debt Issued | 271.73 | 183.92 | 104.45 | 60 | 227.37 |
Total Debt Issued | 271.73 | 183.92 | 104.45 | 60 | 227.37 |
Long-Term Debt Repaid | -208.47 | -168.21 | -80.41 | -164.45 | -134.02 |
Total Debt Repaid | -208.47 | -168.21 | -80.41 | -164.45 | -134.02 |
Net Debt Issued (Repaid) | 63.26 | 15.71 | 24.04 | -104.45 | 93.35 |
Issuance of Common Stock | - | - | - | - | 3.54 |
Common Dividends Paid | -27.68 | -17.67 | -10.6 | -24.14 | -35.92 |
Financing Cash Flow | 35.58 | -1.96 | 13.44 | -128.6 | 60.97 |
Foreign Exchange Rate Adjustments | -4.12 | -0.51 | -0.08 | 12.79 | 0.96 |
Net Cash Flow | 128.6 | 49.32 | -21.77 | -88.23 | -97.67 |
Free Cash Flow | 266.27 | 198.06 | 80.65 | 266.18 | 159.99 |
Free Cash Flow Growth | 34.44% | 145.58% | -69.70% | 66.37% | 98.70% |
Free Cash Flow Margin | 18.54% | 14.15% | 7.66% | 21.58% | 12.64% |
Free Cash Flow Per Share | 0.45 | 0.34 | 0.14 | 0.45 | 0.27 |
Cash Interest Paid | 10.02 | 12.77 | 10.4 | 6.24 | 3.79 |
Cash Income Tax Paid | 15.77 | 10.61 | 9.54 | -12.88 | 64.18 |
Levered Free Cash Flow | 28.64 | 49.6 | -44.97 | 68.9 | -177.85 |
Unlevered Free Cash Flow | 35.42 | 58.24 | -37.92 | 73.04 | -175.1 |
Change in Working Capital | 56.37 | -50.99 | -78.33 | -15.01 | 64.52 |